|
|
|
|
Synthetic HDL: A new weapon to fight cholesterol problems
EVANSTON, Ill.--- Buttery Christmas cookies, eggnog, juicy beef roast, rich gravy and creamy New York-style cheesecake. Happy holiday food unfortunately can send blood cholesterol levels sky high. Northwestern University...
|
|
|
Synthetic HDL: A new weapon to fight cholesterol problems
EVANSTON, Ill.--- Buttery Christmas cookies, eggnog, juicy beef roast, rich gravy and creamy New York-style cheesecake. Happy holiday food unfortunately can send blood cholesterol levels sky high. Northwestern University...
|
|
|
FDA Issues Update to Safety Review on Cholesterol-Lowering Drugs
More than 100 credit cards available at uscards.com General Health: Government Last Updated: Jan 9, 2009 - 8:30:13 AM By FDA Jan 9, 2009 - 8:28:54 AME.mail t.his a.rticle P.rinter f.riendly p.age Get n.ewsletterNote to Correspondents FOR...
|
|
|
FDA backs cholesterol drug Vytorin after review
The U.S.Food and Drug Administration says patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A statement from the...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA Issues Update to Safety Review on Cholesterol-Lowering Drugs
FDA?s comments are contained in an update to its Jan.25, 2008, Early Communication describing the agency?s review of data from ENHANCE, a clinical trial comparing Zocor (simvastatin), a drug that lowers cholesterol production in the...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.- The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA backs Vytorin after finishing study review
By LINDA A.JOHNSON The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
FDA finishes review of study, backs Vytorin
TRENTON, N.J.-- The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA Declares: Keep Taking Your Vytorin
Its official.Vytorin (ezetimibe/simvastatin) still does what its supposed to dosignificantly decrease LDL cholesterol. FDA, yesterday, released its assessment of the now-notorious ENHANCE trialwhich tested whether Vytorin was...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.(AP) - The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.(AP) - The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.(AP) - The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.(AP) - The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
Update of Safety Review Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for
FDA announced that it would be reviewing data from the ENHANCE trial (Effect of Combination Ezetimibe and High-Dose Simvastatin vs.Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.- The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.- The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA study review backs Vytorin
TRENTON, N.J.-- The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A...
|
|
|
FDA backs Vytorin after finishing study review
(AP) TRENTON, N.J.- The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.(AP) The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales.
|
|
|
FDA backs Vytorin after finishing study review
TRENTON, N.J.(AP) - The Food and Drug Administration said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales....
|
|
|
FDA Backs Cholesterol Drug Vytorin
Review says it lowered bad cholesterol more effectively than Zocor THURSDAY, Jan.8 (HealthDay News) -- After nearly a year of review, U.S. health officials said Thursday that they supported the continued use of the controversial ...
|
|
|
FDA backs Vytorin after finishing study review
Trenton, N.J.-- The said Thursday patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales. A statement from the...
|
